|
PIGK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.09179999672338E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.75700000051948E-07 |
| Normal-vs-Stage2 |
1.09619999999477E-06 |
| Normal-vs-Stage3 |
3.62310000000532E-05 |
| Normal-vs-Stage4 |
1.395200E-03 |
| Stage1-vs-Stage2 |
3.427400E-01 |
| Stage1-vs-Stage3 |
7.185800E-01 |
| Stage1-vs-Stage4 |
8.554400E-01 |
| Stage2-vs-Stage3 |
7.159200E-01 |
| Stage2-vs-Stage4 |
7.243400E-01 |
| Stage3-vs-Stage4 |
9.595200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27309999986558E-07 |
| Normal-vs-AfricanAmerican |
4.99419999999695E-06 |
| Normal-vs-Asian |
3.972200E-02 |
| Caucasian-vs-AfricanAmerican |
8.326000E-01 |
| Caucasian-vs-Asian |
8.053800E-01 |
| AfricanAmerican-vs-Asian |
7.292000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94289999644326E-08 |
| Normal-vs-Female |
2.209500E-04 |
| Male-vs-Female |
6.002500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.8201999996712E-07 |
| Normal-vs-Extreme_Weight |
5.08799999909826E-08 |
| Normal-vs-Obese |
1.612610E-04 |
| Normal-vs-Extreme_Obese |
1.004020E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.737400E-01 |
| Normal_Weight-vs-Obese |
1.760640E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.178600E-01 |
| Extreme_Weight-vs-Obese |
2.414400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.973400E-01 |
| Obese-vs-Extreme_Obese |
5.140600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.446300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.5342099999982E-05 |
| Normal-vs-Age(61-80Yrs) |
3.37619999735139E-08 |
| Normal-vs-Age(81-100Yrs) |
2.45489999999293E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.990800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.419600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.856400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.377630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.514000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.440200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99749999985066E-07 |
| Normal-VS-Type2 PRCC |
5.93290000017177E-07 |
| Normal-VS-KIRP CIMP |
3.084800E-03 |
| Normal-VS-Unclassified PRCC |
8.036600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.912000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.951000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.572380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.399600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.107800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.425400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.05370001612926E-09 |
| Normal-vs-N1 |
2.983300E-03 |
| Normal-vs-N2 |
1.002580E-01 |
| N0-vs-N1 |
5.070200E-02 |
| N0-vs-N2 |
2.600600E-01 |
| N1-vs-N2 |
9.420200E-01 |
|
|
